After completion of a number of validation shipments Maverick New Zealand has commenced ongoing production of device tissues this month against a clients need for a dual sourced supply chain to meet regulatory requirements, and board directives to manage disease risk.

Any seasonal impacts of the winter slowdown common with New Zealand slaughtering will be ably covered with Australian production produced and shipped in complete accordance with client requirements, during this period.